Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3583 (109th)

Protecting Free Trade in Pharmaceuticals Act of 2005

referredUnited States· United States Congress· EN

Introduced

28 July 2005

Last action

4 August 2005 · Referred

Status

Referred to the Subcommittee on Trade.

Sponsors

Rep. Northup, Anne M. [R-KY-3], Rep. DeLauro, Rosa L. [D-CT-3], Sen. Brown, Sherrod [D-OH], Rep. Emerson, Jo Ann [R-MO-8], Rep. Berry, Marion [D-AR-1], Sen. Sanders, Bernard [I-VT], Rep. Emanuel, Rahm [D-IL-5], Rep. Gutknecht, Gil [R-MN-1], Rep. Simpson, Michael K. [R-ID-2], Rep. Allen, Thomas H. [D-ME-1], Rep. Crowley, Joseph [D-NY-14]

Subjects

Transport

Source updated

5 December 2025

Transport

Summary

Protecting Free Trade in Pharmaceuticals Act of 2005 - Amends the Bipartisan Trade Promotion Authority Act of 2002 to include among the overall trade negotiating objectives of the United States avoiding negotiating trade agreements that could restrict, or be interpreted to restrict, the access of consumers in the United States to pharmaceutical imports from countries with a pharmaceutical infrastructure that is equivalent, or superior, to that of the United States: (1) by or through the use and development of the doctrine of international patent exhaustion, as interpreted or applied by U.S. courts on the enactment of this Act; or (2) by making it a violation for the United States to enact legislation permitting pharmaceutical imports without the consent of patent owners when the products involved have been sold outside the United States. Prohibits the U.S. Trade Representative (USTR) from: (1) entering into a bilateral or multilateral trade agreement that, with respect to the importation of pharmaceutical products without the consent of the patent owners, includes provisions identical or similar to the provisions of the United States-Singapore Free Trade Agreement, the United States-Australia Free Trade Agreement, or the United States-Morocco Free Trade Agreement; or (2) negotiating an agreement or understanding with respect to any of such provisions. Requires the USTR, with respect to the advisory committee on matters relating to intellectual property, to ensure that, for each meeting that relates or potentially relates to the importation of pharmaceutical products into the United States, at least 10% of the committee members represent the interests of consumers of such products.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 July 2005

    Introduced

    Referred to the House Committee on Ways and Means.

    Source: IntroReferral

  2. 28 July 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 July 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 4 August 2005

    Referred

    Referred to the Subcommittee on Trade.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 July 2005

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 28 July 2005

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 July 2005

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.